BASF acquires Verenium, a San Diego-based enzyme supplier.
BASF Acquires Enzyme Company 10-16-2013 BASF Corp. (Los Angeles) has acquired enzyme specialist Verenium (San Diego) to the tune of $62 million. The acquisition is expected to strengthen BASF’s position in the growing global enzyme market.
BASF purchased shares in Verenium at $4 each, an estimated 56% premium over the average share price recorded six months prior to the transaction. The transaction is expected to close once BASF can secure a majority of the remaining outstanding shares. In 2012, Verenium made $57 in revenue.
The Nutritional Outlook Podcast Episode 33: Keeping up with contract manufacturing
July 26th 2024Nutritional Outlook talks to Lauren Samot, commercial innovation leader, and Blayney McEneaney, sales executive at Vitaquest International, about trends within the contract manufacturing space, and the ways in which contract manufacturers like Vitaquest keep up with the market and differentiate themselves from the competition.